Sulfonylamino-derivatives as novel inhibitors of histone deacetylase

Details for Australian Patent Application No. 2003209727 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Verdonck, Marc Gustaaf Celine; Van Brandt, Sven Franciscus Anna; Angibaud, Patrick Rene; Van Emelen, Kristof; De Winter, Hans Louis Jos; Pilatte, Isabelle Noelle Constance; Van heusden, Jimmy Arnold Viviane; Backx, Leo Jacobus Jozef

Agent Shelston IP

Pub. Number AU-B-2003209727

PCT Number PCT/EP03/02517

PCT Pub. Number WO2003/076401

Priority PCT/EP02/14481 18.12.02 EP; 60/363,799 13.03.02 US

Filing date 11 March 2003

Wipo publication date 22 September 2003

Acceptance publication date 16 October 2008

International Classifications

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/451 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61K 31/4545 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 13/10 (2006.01) Drugs for disorders of the urinary system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 207/14 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 211/58 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): PCT/EP02/14481 18.12.02 EP; 60/363,799 13.03.02 US

30 October 2003 Application Open to Public Inspection

  Published as AU-B-2003209727

8 September 2005 Amendment Made

  The nature of the amendment is: Add co-inventor Van heusden, Jimmy Arnold Viviane

16 October 2008 Application Accepted

  Published as AU-B-2003209727

12 February 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003209728-CYCLOPENTENE DERIVATIVES

2003209726-CATALYST-PRECURSOR FOR THE PRODUCTION OF MALEIC ACID ANHYDRIDE AND METHOD FOR THE PRODUCTION THEREOF